Generated by All in One SEO v4.9.0, this is an llms.txt file, used by LLMs to index the site. # Inspira Breathing. Empowered. ## Sitemaps - [XML Sitemap](https://inspira-technologies.com/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution](https://inspira-technologies.com/inspira-announces-1-8-million-registered-direct-offering-priced-at-the-market-and-additional-equity-financing-agreement-to-support-ongoing-commercial-execution/) - [Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use](https://inspira-technologies.com/inspira-technologies-granted-patent-in-japan-for-the-inspira-art-systems-convertible-dual-lumen-cannula-device-and-method-of-use/) - [Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology](https://inspira-technologies.com/inspira-technologies-announces-strategic-leap-in-lab-capabilities-accelerating-next-generation-diagnostics-and-blood-technology/) - [Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission](https://inspira-technologies.com/inspira-completes-clinical-study-for-hyla-blood-sensor-ahead-of-regulatory-submission/) - [Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion](https://inspira-technologies.com/inspira-technologies-nears-final-regulatory-clearance-for-the-art100-in-the-uae-accelerating-gulf-region-expansion/) - [Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira’s Global Ecosystem](https://inspira-technologies.com/inspira-and-bites-form-strategic-alliance-to-embed-ai-as-a-core-standard-across-inspiras-global-ecosystem/) - [Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm](https://inspira-technologies.com/inspira-appoints-former-johnson-johnson-executive-as-vp-of-global-sales-and-new-board-member-from-a-leading-international-investment-firm/) - [Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update](https://inspira-technologies.com/inspira-technologies-reports-first-half-2025-financial-results-and-issues-business-update/) - [Inspira to Unveil HYLA™ Real-Time Blood Sensor at U.S. ELSO; 97.35% Accuracy Confirmed](https://inspira-technologies.com/inspira-to-unveil-hyla-real-time-blood-sensor-at-u-s-elso-97-35-accuracy-confirmed/) - [Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance](https://inspira-technologies.com/inspira-announces-97-3-accuracy-results-for-hyla-blood-sensor-advancing-toward-fda-submission-for-clearance/) - [Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024](https://inspira-technologies.com/inspira-to-publish-hyla-clinical-results-in-fourth-quarter-2024/) - [Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product](https://inspira-technologies.com/inspira-technologies-announces-fda-listing-and-market-readiness-of-new-product/) - [Top U.S. Honor Roll Hospital Expands Use of INSPIRA™ ART100 System to Lung Transplant Procedures](https://inspira-technologies.com/top-u-s-honor-roll-hospital-expands-use-of-inspira-art100-system-to-lung-transplant-procedures/) - [Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market](https://inspira-technologies.com/inspira-receives-u-s-patent-approval-for-the-art500-core-technology-key-patent-positions-the-company-to-dominate-20-billion-estimated-market/) - [Inspira Secures $27 Million Government Binding Purchase Order for ART100 Systems with Full Payment in 2025](https://inspira-technologies.com/inspira-secures-27-million-government-binding-purchase-order-for-art100-systems-with-full-payment-in-2025/) - [Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years](https://inspira-technologies.com/inspira-clarifies-routine-nature-of-registration-statement-on-form-f-3-filing-performed-every-three-years/) - [Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives](https://inspira-technologies.com/inspira-activates-u-s-based-consulting-firm-to-execute-transformational-initiatives/) - [Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement](https://inspira-technologies.com/inspira-regains-compliance-with-nasdaq-minimum-bid-price-requirement/) - [Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100](https://inspira-technologies.com/inspira-achieves-all-key-objectives-in-previously-announced-government-talks-forging-a-pathway-to-national-adoption-and-global-scale-up-of-the-art100/) - [Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework](https://inspira-technologies.com/inspira-in-high-level-government-talks-to-advance-national-integration-of-the-art100-and-establish-a-global-distribution-framework/) - [Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase](https://inspira-technologies.com/inspira-technologies-secures-22-5-million-purchase-order-launches-full-revenue-execution-phase/) - [INSPIRA™ ART100 Receives FDA 510(k) Clearance](https://inspira-technologies.com/inspira-art100-receives-fda-510k-clearance/) - [Inspira™ Announces Start of Production of the INSPIRA™ ART100](https://inspira-technologies.com/inspira-announces-start-of-production-of-the-inspira-art100/) - [Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100](https://inspira-technologies.com/inspira-receives-csa-certification-of-compliance-to-u-s-standards-for-the-inspira-art100/) - [Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures](https://inspira-technologies.com/inspira-signs-term-sheet-for-use-of-inspira-art100-device-in-organ-transplant-procedures/) - [Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections](https://inspira-technologies.com/inspira-and-ennocure-in-vitro-study-results-show-100-prevention-of-bacterial-growth-that-causes-bloodstream-infections/) - [Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb](https://inspira-technologies.com/inspira-announces-program-to-pioneer-the-applicable-use-of-the-inspira-art100-device-for-an-artificial-womb/) - [Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager](https://inspira-technologies.com/inspira-announces-1-65-million-registered-direct-offering-of-ordinary-shares-by-inspira-ceos-mother-with-leading-fund-manager/) - [Inspira™ Technologies Reports Full Year 2023 Financial Results](https://inspira-technologies.com/inspira-technologies-reports-full-year-2023-financial-results/) - [Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets](https://inspira-technologies.com/inspira-announces-amar-regulatory-submission-of-the-inspira-art100-to-enter-the-southeast-asia-and-south-american-markets/) - [Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator](https://inspira-technologies.com/inspira-releases-new-data-demonstrating-superiority-of-its-core-technology-across-key-endpoints-of-hmss-indicator/) - [Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days](https://inspira-technologies.com/inspira-announces-plans-to-report-the-primary-results-for-a-core-blood-oxygenation-technology-within-days/) - [Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone](https://inspira-technologies.com/inspira-to-host-conference-call-to-discuss-investor-presentation-and-announce-next-major-milestone/) - [Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements](https://inspira-technologies.com/inspira-announces-breakthrough-update-nears-first-fda-510k-approval-3-u-s-patents-approved-546-million-in-summary-distribution-agreements/) - [Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies](https://inspira-technologies.com/inspira-introduces-high-end-platform-for-bio-mimicking-blood-parameters-for-development-and-testing-of-core-technologies/) - [Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System](https://inspira-technologies.com/inspira-receives-first-ever-u-s-patent-approval-for-an-orbiting-blood-oxygenation-delivery-system/) - [Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device](https://inspira-technologies.com/inspira-technologies-collaborates-with-a-leading-israeli-medical-center-for-clinical-evaluation-of-inspira-art-device/) - [Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices](https://inspira-technologies.com/inspira-technologies-signs-strategic-agreement-to-enter-gulf-states-with-glo-med-for-deployment-of-531-inspira-art-devices/) - [Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives](https://inspira-technologies.com/inspira-technologies-aligns-executive-team-amid-corporate-structuring-initiatives/) - [Inspira’s ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions](https://inspira-technologies.com/inspiras-art100-in-use-at-tier-1-u-s-hospitals-generating-strong-clinical-interest-and-accelerating-sales-discussions/) - [Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority](https://inspira-technologies.com/inspira-scales-up-art100-production-capabilities-amid-advanced-negotiation-with-european-government-authority/) - [Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System](https://inspira-technologies.com/inspira-technologies-initiates-global-commercial-rollout-of-fda-cleared-art100-system/) - [Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing](https://inspira-technologies.com/inspira-achieves-above-99-gas-exchange-efficiency-in-vortx-technology-in-vivo-animal-testing/) - [Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems](https://inspira-technologies.com/inspira-technologies-generates-first-revenues-from-deployment-of-inspira-art100-systems/) - [Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center](https://inspira-technologies.com/inspira-technologies-announces-successful-treatment-of-first-patient-with-inspira-art100-at-westchester-medical-center/) - [INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients](https://inspira-technologies.com/inspira-art100-system-approved-by-israels-largest-healthcare-provider-for-use-in-organ-transplant-patients/) - [Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital](https://inspira-technologies.com/inspira-technologies-announces-successful-installation-of-inspira-art100-systems-in-premier-u-s-hospital/) - [Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care](https://inspira-technologies.com/inspira-technologies-releases-ceo-update-major-milestones-signal-next-level-respiratory-care/) - [Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates](https://inspira-technologies.com/inspira-technologies-reports-full-year-2024-financial-results-and-provides-business-updates/) - [AI Meets Blood Monitoring: How This Innovative Blood Sensor Could Transform Patient Care / by International Business Times](https://inspira-technologies.com/ai-meets-blood-monitoring-how-this-innovative-blood-sensor-could-transform-patient-care/) - [Inspira Technologies: Revolutionizing Life-Support with First Deployments in Leading U.S. Hospital / by Stoxpo](https://inspira-technologies.com/inspira-technologies-revolutionizing-life-support-with-first-deployments-in-leading-u-s-hospital/) - [Inspira Technologies collaborates with Zriha Medical to launch production line / by Seeking Alpha](https://inspira-technologies.com/inspira-technologies-collaborates-with-zriha-medical-to-launch-production-line/) - [Market News: Inspira Technologies Signs a Strategic Potential $32.6M Agreement to Enter Gulf States with Glo-Med / by The Venture Cation](https://inspira-technologies.com/market-news-inspira-technologies-signs-a-strategic-potential-32-6m-agreement-to-enter-gulf-states-with-glo-med/) - [This Medical Technology Company Forms Revolutionary Alliance / by News Break](https://inspira-technologies.com/this-medical-technology-company-forms-revolutionary-alliance/) - [The Evolution of Life Support Healthcare in a Post-COVID World / by News Break](https://inspira-technologies.com/the-evolution-of-life-support-healthcare-in-a-post-covid-world/) - [Direct Oxygenation of Blood—A Gospel for the ICU Field? / by BioPharma Dive](https://inspira-technologies.com/direct-oxygenation-of-blood-a-gospel-for-the-icu-field/) - [MedTech M&A Momentum in 2024: A Focus on Inspira Technologies / by Benzinga](https://inspira-technologies.com/medtech-ma-momentum-in-2024-a-focus-on-inspira-technologies/) - [Ventilation without Anesthesia – The Next Major Leap in Life Support? / by Street Insider](https://inspira-technologies.com/ventilation-without-anesthesia-the-next-major-leap-in-life-support/) - [Understanding Breathing Without Lungs: The Core of Inspira's Innovation / by Benzinga](https://inspira-technologies.com/understanding-breathing-without-lungs-the-core-of-inspiras-innovation-2/) - [Understanding Breathing Without Lungs: The Core of Inspira's Innovation / by Benzinga](https://inspira-technologies.com/understanding-breathing-without-lungs-the-core-of-inspiras-innovation/) - [“Our goal is to ensure that our employees feel safe and secure in their work environment.” / by Calcalist](https://inspira-technologies.com/our-goal-is-to-ensure-that-our-employees-feel-safe-and-secure-in-their-work-environment/) - [חברת המד-טק הישראלית קיבלה מיליון דולר - ותפתח "ריאה מלאכותית" / by Ice](https://inspira-technologies.com/חברת-המד-טק-הישראלית-קיבלה-מיליון-דולר/) - [Inspira Granted U.S. Patent, Pioneering the Future in the $20 Billion Respiratory Life Support Market / by Market Sherald](https://inspira-technologies.com/inspira-granted-u-s-patent-pioneering-the-future-in-the-20-billion-respiratory-life-support-market/) - [Israel's Inspira & Its Cutting-Edge Respiratory Care / by News Max](https://inspira-technologies.com/israels-inspira-its-cutting-edge-respiratory-care/) - [New US Patent Propels Inspira Technologies Ahead in the $20 Billion Respiratory Care Arena / by Startup Mafia](https://inspira-technologies.com/new-us-patent-propels-inspira-technologies-ahead-in-the-20-billion-respiratory-care-arena/) - [We are the start-up nation / by Ynet](https://inspira-technologies.com/we-are-the-start-up-nation/) - [חברת אינספירה טכנולוגיות (Inspira™ Technologies) חותמת על הסכם הפצה למוצרי החברה במרכז אמריקה עם חברת CIO MED GROUP / by Ynet](https://inspira-technologies.com/חברת-אינספירה-טכנולוגיות-inspira-technologies-חותמת/) - [Breaking News: Inspira Technologies Ventures into Central America with a Landmark $28 Million Distribution Deal / by Benzinga](https://inspira-technologies.com/breaking-news-inspira-technologies-ventures-into-central-america-with-a-landmark-28-million-distribution-deal/) - [The Jewess Patriot: Inspira from Israel Solves Respiratory Care / by Times of Israel](https://inspira-technologies.com/the-jewess-patriot-inspira-from-israel-solves-respiratory-care/) - [Intubation could become a relic of the Covid era / by israel21c](https://inspira-technologies.com/intubation-could-become-a-relic-of-the-covid-era/) - [The Definitive Rap: Israel’s New Invention Inspira ART500 Oxygenating Blood Without Intubation / by 5townscentral](https://inspira-technologies.com/the-definitive-rap-israels-new-invention-inspira-art500-oxygenating-blood-without-intubation/) - [Israeli Details What America Can Do To Help / by Rumble](https://inspira-technologies.com/israeli-details-what-america-can-do-to-help/) - [Inspira Technologies will present its "artificial lungs" technology in front of family offices from all over the world / by Campden FB](https://inspira-technologies.com/inspira-technologies-will-present-its-artificial-lungs-technology-in-front-of-family-offices-from-all-over-the-world/) - [Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure / by Benzinga](https://inspira-technologies.com/inspira-technologies-the-company-that-aims-to-change-50-years-of-therapeutic-paradigm-in-patients-with-respiratory-failure/) - [Third Quarter Financial Reports Results / by Benzinga](https://inspira-technologies.com/third-quarter-financial-reports-results/) - ["Millions May Soon Breath Better" - Inspira / by Forbes](https://inspira-technologies.com/millions-may-soon-breath-better/) - Inspira Technologies and the ART device at Forbes! Featured in Carrie Rubinstein's amazing article. - [Inspira Technologies’ “Artificial Lung” To Acquire A Digital Edge: The Company Contracted GlobalLogic, A Hitachi Group Company, For Advanced Digital Product Engineering Services / by Yahoo Finance](https://inspira-technologies.com/inspira-technologies-artificial-lung-to-acquire-a-digital-edge-the-company-contracted-globallogic-a-hitachi-group-company-for-advanced-digital-product-engineering-service/) - [Low Flow Extracorporeal Oxygenation Approach Is The Future Of Acute Respiratory Care / by Infomed News](https://inspira-technologies.com/low-flow-extracorporeal-oxygenation-approach-is-the-future-of-acute-respiratory-care/) - [An Interview With Dagi Ben-Noon, CEO At Inspira Technologies / by SuperbCrew](https://inspira-technologies.com/an-interview-with-dagi-ben-noon-ceo-at-inspira-technologies/) - [Top 115 Medical And Healthcare Startups In Israel / by Medical Startups](https://inspira-technologies.com/top-115-medical-and-healthcare-startups-in-israel/) - [EXCLUSIVE: Inspira Aims To Replace Mechanical Ventilation With Augmented Respiratory Technology / by Benzinga](https://inspira-technologies.com/exclusive-inspira-aims-to-replace-mechanical-ventilation-with-augmented-respiratory-technology/) - [10+ Best Healthcare Startups: Inspiration And Brave Findings Nearby / by PR News](https://inspira-technologies.com/10-best-healthcare-startups-inspiration-and-brave-findings-nearby/) - [The Future Of Respiratory By Inspira Technologies: Breathing Without Lungs / by The Stocker News](https://inspira-technologies.com/the-future-of-respiratory-by-inspira-technologies-breathing-without-lungs/) - [Q&A: An Intelligent Oxygenation System That Could Eliminate Need For Ventilators / by Med Tech News](https://inspira-technologies.com/qa-an-intelligent-oxygenation-system-that-could-eliminate-need-for-ventilators/) - [Hillel’s Tech Corner: Inspira Makes Breathing Easy / by Jpost](https://inspira-technologies.com/hillels-tech-corner-inspira-makes-breathing-easy/) - [Sheba And Inspira Technologies Implement Respiratory Treatment For Covid-19 Patients / by Calcalist](https://inspira-technologies.com/sheba-and-inspira-technologies-implement-respiratory-treatment-for-covid-19-patients/) - [Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy](https://inspira-technologies.com/inspira-technologies-announces-positive-results-from-clinical-study-of-hyla-blood-sensor-achieving-96-accuracy/) - [Inspira Technologies Interview | Stocks To Buy 2025 NASDAQ: IINN](https://inspira-technologies.com/inspira-technologies-interview-stocks-to-buy-2025-nasdaq-iinn/) - [Inspira New Investor Presentation](https://inspira-technologies.com/inspira-new-investor-presentation/) - [A Breath of Fresh Air: Inspira Technologies Offers an Innovative Approach to Acute Respiratory Care](https://inspira-technologies.com/a-breath-of-fresh-air-inspira-technologies-offers-an-innovative-approach-to-acute-respiratory-care/) - [Inspira Technologies: A Billion Dollar Market Opportunity for only 5-10% Market Share](https://inspira-technologies.com/inspira-technologies-a-billion-dollar-market-opportunity-for-only-5-10-market-share/) - [Inspira: Using AI and Advanced Algorithms to Redefine Patient Outcomes](https://inspira-technologies.com/inspira-using-ai-and-advanced-algorithms-to-redefine-patient-outcomes/) - [Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections](https://inspira-technologies.com/inspira-achieves-positive-results-of-above-95-for-preventing-bloodstream-infections/) - [Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor](https://inspira-technologies.com/inspira-technologies-integrates-new-oxygenation-indicator-into-ai-powered-hyla-blood-sensor/) - [Inspira™ Technologies Reports Second Quarter 2023 Financial Results](https://inspira-technologies.com/inspira-technologies-reports-second-quarter-2023-financial-results/) - As of June 30, 2023, the Company had $8.9 million in cash, cash equivalents and short-term bank deposits. For the full report, please click here. - [Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices](https://inspira-technologies.com/inspira-signs-agreement-expansion-with-innovimed-for-clinical-trials-of-inspira-art-respiratory-medical-devices/) - [Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization](https://inspira-technologies.com/inspira-announces-510k-fda-submission-of-inspira-art100-towards-commercialization/) - [Inspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical Device](https://inspira-technologies.com/inspira-granted-u-s-patent-for-inspira-art500-medical-device/) - [Inspira™ Terminates ATM Program and Provides an Update](https://inspira-technologies.com/inspira-terminates-atm-program-and-provides-an-update/) - [Inspira™ Enters into a Distribution Agreement in Central America with CIO MED GROUP](https://inspira-technologies.com/inspira-enters-into-a-distribution-agreement-in-central-america-with-cio-med-group/) - [Inspira™ Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients](https://inspira-technologies.com/inspira-collaborates-with-ennocure-for-development-of-a-proprietary-bio-electronic-treatment-to-prevent-associated-bloodstream-infections-in-icu-patients/) - [Inspira™ Technologies Reports Third Quarter 2023 Financial Results](https://inspira-technologies.com/inspira-technologies-reports-third-quarter-2023-financial-results/) - [Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology](https://inspira-technologies.com/inspira-announces-israeli-innovation-authority-grant-for-new-vortx-disposable-blood-oxygenation-technology/) - [Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering](https://inspira-technologies.com/inspira-technologies-closes-on-3-88-million-registered-direct-offering/) - [Inspira™ Announces $3.88 Million Registered Direct Offering](https://inspira-technologies.com/inspira-announces-3-88-million-registered-direct-offering/) - [Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024](https://inspira-technologies.com/inspira-announces-95-accuracy-results-for-hyla-blood-sensor-planning-fda-submission-for-clearance-in-2024/) - [Inspira™ Technologies to Participate in J.P. Morgan Healthcare Conference](https://inspira-technologies.com/inspira-technologies-to-participate-in-j-p-morgan-healthcare-conference/) - [In Preparation for FDA Clearance and Device Deployment, Inspira™ has Appointed Dr. Dan Gorfil, to Medical Advisory Board](https://inspira-technologies.com/in-preparation-for-fda-clearance-and-device-deployment-inspira-has-appointed-dr-dan-gorfil-to-medical-advisory-board/) - [Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity](https://inspira-technologies.com/inspira-announces-plans-to-launch-and-target-single-use-disposable-blood-oxygenation-kit-for-a-new-disposable-perfusion-market-opportunity/) - [Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support](https://inspira-technologies.com/inspira-introduces-advanced-features-for-inspira-art100-further-amplifying-user-and-system-support/) - [Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital](https://inspira-technologies.com/inspira-technologies-prepares-its-first-life-support-systems-for-deployment-at-a-leading-u-s-hospital/) - [Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors](https://inspira-technologies.com/inspira-announces-the-appointment-of-tal-parnes-as-the-new-chairman-of-the-board-bringing-vast-experience-in-the-medical-technology-and-pharmaceutical-sectors/) - [Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line](https://inspira-technologies.com/inspira-technologies-collaborates-with-zriha-medical-to-launch-cutting-edge-production-line/) - [Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology](https://inspira-technologies.com/inspira-technologies-unveils-modular-configuration-for-revolutionary-vortx-blood-oxygenation-delivery-technology/) - [Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China](https://inspira-technologies.com/inspira-preparing-production-in-response-to-spread-of-respiratory-virus-in-china/) - [Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai](https://inspira-technologies.com/inspira-technologies-flagship-technology-to-be-showcased-at-arab-health-expo-2025-in-dubai/) - [Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company](https://inspira-technologies.com/inspira-announces-pricing-of-3-2m-private-placement-by-new-and-existing-investors-of-the-company/) - [Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment](https://inspira-technologies.com/inspira-technologies-delivers-systems-to-leading-distributor-for-u-s-deployment/) - [Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions](https://inspira-technologies.com/inspira-expands-hyla-blood-sensor-technology-into-personalized-blood-lab-testing-for-rapid-detection-of-serious-medical-conditions/) - [Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios](https://inspira-technologies.com/inspira-collaborates-with-new-yorks-westchester-medical-center-to-evaluate-the-inspira-art100-functionality-and-performance-in-clinical-scenarios/) - [Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism](https://inspira-technologies.com/inspira️-announces-development-of-new-disposable-kit-with-built-in-performance-monitoring-mechanism/) - [Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100](https://inspira-technologies.com/inspira-announces-establishment-of-distribution-facility-to-support-u-s-deployment-of-inspira-art100/) - [Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECMOs Conference in Israel](https://inspira-technologies.com/inspira-introduces-advanced-life-support-solutions-to-key-international-leaders-at-the-annual-iecos-conference-in-israel/) - [Inspira™ Launches INSPIRA™ ART100 at the World’s Largest Extracorporeal Life Support Conference](https://inspira-technologies.com/inspira-launches-inspira-art100-at-the-worlds-largest-extracorporeal-life-support-conference/) - [Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System](https://inspira-technologies.com/inspira-secures-a-second-u-s-patent-approval-for-orbiting-blood-oxygenation-delivery-system/) - [Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 – Results Exceed 100% at Maximum Flow](https://inspira-technologies.com/inspira-approached-by-large-medical-company-to-evaluate-operation-of-their-key-product-with-inspira-art100-results-exceed-100-at-maximum-flow/) - [Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest](https://inspira-technologies.com/inspira-technologies-introduces-the-inspira-cardi-art-aiming-to-provide-oxygen-to-the-brain-during-cardiac-arrest/) - [Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System](https://inspira-technologies.com/inspira-receives-israeli-regulatory-approval-for-the-inspira-art100-system/) - [Company Conference Call - March 2024](https://inspira-technologies.com/company-conference-call-march-2024/) - [Inspira™ Announces Business Plan Targets](https://inspira-technologies.com/inspira-announces-business-plan-targets/) - [Inspira™ Technologies to Present Advanced Respiratory Solutions to Key International Leaders at the Annual iECOs Conference in Tel Aviv, Israel](https://inspira-technologies.com/inspira-technologies-to-present-advanced-respiratory-solutions-to-key-international-leaders-at-the-annual-iecos-conference-in-tel-aviv-israel/) - [Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.](https://inspira-technologies.com/inspira-receives-first-ever-purchase-order-for-inspira-art100-systems-in-the-u-s/) - [Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector](https://inspira-technologies.com/inspira-to-exhibit-the-fda-cleared-inspira-art100-system-at-a-world-renowned-event-in-the-sector/) - [Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments](https://inspira-technologies.com/inspira-technologies-announces-business-targets-presentation-following-fda-clearance-and-significant-developments/) - [Creating a Paradigm Shift in Respiratory Care: Early Respiratory Support Reducing the Need for Invasive Mechanical Ventilation / by HAARETZ](https://inspira-technologies.com/creating-a-paradigm-shift-in-respiratory-care-early-respiratory-support-reducing-the-need-for-invasive-mechanical-ventilation/) - https://www.haaretz.com/haaretz-labels/2023-01-04/ty-article-labels/.premium/creating-a-paradigm-shift-in-respiratory-care/00000185-7c5c-d464-a197-fe7ff7ec0000 - [Inspira™ Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRA™ ART System](https://inspira-technologies.com/inspira-technologies-granted-patent-by-the-israeli-patent-office-for-key-safety-component-for-the-inspira-art-system/) - Ra’anana, Israel, November 10, 2022 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that the Israeli Patent Office (ILPO) granted a patent for a key safety component of the INSPIRA™ ART system. The component is to be located on the patient’s - [Inspira™ Technologies Strategically Plans to Actualize Hundreds of Millions in Conditional Distribution Agreements / by Benzinga](https://inspira-technologies.com/inspira-technologies-strategically-plans-to-actualize-hundreds-of-millions-in-conditional-distribution-agreements/) - [The Disruptive MedTech Company Aiming to Minimise Patients' Need for Invasive Mechanical Ventilation Intervention / by Campden FB](https://inspira-technologies.com/the-disruptive-medtech-company-aiming-to-minimise-patients-need-for-invasive-mechanical-ventilation-intervention/) - [INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.](https://inspira-technologies.com/inspira-art100-completes-usability-study-in-boston-massachusetts-u-s/) - Ra’anana, Israel, August 9, 2023 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care by empowering breathing without lungs, is proud to announce it has completed a Usability Study in Boston, Massachusetts for its INSPIRA ART100 device. The Usability Study included - [Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval](https://inspira-technologies.com/inspira-technologies-receives-certification-of-medical-devices-quality-management-systems-another-step-towards-eu-regulatory-approval/) - Ra’anana, Israel, July 24, 2023 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, is proud to announce it has received International Organization for Standardization (ISO) 13485:2016 Standard Certification, which is the international standard for quality management systems within the medical - [Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.](https://inspira-technologies.com/inspira-technologies-enters-into-collaboration-agreement-with-u-s-based-perfusion-solution-inc/) - Perfusion Solution, Inc. is a leading U.S.-based company that provides a platform of advanced medical devices, training and staffing to leading U.S. hospitals. Ra’anana, Israel, July 19, 2023 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, announced today that it - [Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care](https://inspira-technologies.com/inspira-technologies-unveils-investor-deck-showcasing-revolutionary-advancement-in-acute-respiratory-care/) - Ra’anana, Israel June 15, 2023 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, is thrilled to present our latest investor deck (the “Investor Deck”), unveiling unparalleled opportunities that have the potential to reshape the acute respiratory care landscape introducing empowered breathing - [Inspira Technologies Appoints Dr. Nir as Chief Medical Officer](https://inspira-technologies.com/inspira-technologies-appoints-dr-nir-as-chief-medical-officer/) - Dr. Nir is a clinical strategy expert with market experience Ra’anana, Israel, May 30, 2023 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, has announced the appointment of Dr. Adi Rizansky Nir, PhD to the position of Chief Medical Officer (“CMO”). Dr. - [Inspira™ Technologies Reports First Quarter 2023 Financial Results](https://inspira-technologies.com/inspira-technologies-reports-first-quarter-2023-financial-results/) - As of March 31, 2023, the Company had $11.5 million in cash, cash equivalents, and short-term bank deposits. For the full report, please click here. - [Inspira™ Technologies will Reveal the New ALICE™ Device at the World’s Largest Extracorporeal Life Support Conference](https://inspira-technologies.com/inspira-technologies-will-reveal-the-new-alice-device-at-the-worlds-largest-extracorporeal-life-support-conference/) - The ELSO conference is a consortium of healthcare institutions, researchers, and industry partners Ra’anana, Israel, May 16, 2023 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, has announced today it will reveal the new ALICETM device at the world’s largest Extracorporeal - [Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide](https://inspira-technologies.com/inspira-technologies-is-developing-the-vortxtm-blood-oxygenator-a-unique-technology-for-saturating-blood-with-oxygen-and-removing-carbon-dioxide-total-addressable-market-is-currently/) - Total addressable market is currently estimated at $1.16 billion. Ra’anana, Israel, May 11, 2023 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, today announced the development of the VORTXTM Blood Oxygenator, an Augmented Respiration Technology based on a new breakthrough technological - [Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results](https://inspira-technologies.com/inspira-technologies-reports-fourth-quarter-2022-and-full-year-financial-results/) - As of December 31, 2022, the Company had $13.9 million in cash, cash equivalents, and deposits. For the full report, please click here - [Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study](https://inspira-technologies.com/first-use-in-human-hyla-blood-sensor-clinical-study/) - First use of HYLA in a patient undergoing open-heart surgery at Sheba Medical Center in Israel Ra’anana, Israel, March 22, 2023 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, has announced today the first in human of a patient undergoing - [VP operations presents the start of ALICE™ Device manufacturing](https://inspira-technologies.com/vp-operations-presents-the-start-of-alice-device-manufacturing/) - [Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor](https://inspira-technologies.com/inspira-technologies-receives-approval-from-sheba-medical-center-to-conduct-clinical-study-of-the-hyla-blood-sensor/) - The clinical study is planned for Q1-2023 to be performed on patients undergoing open-heart surgery at Sheba Medical Center Ra’anana, Israel, February 13, 2023 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company creating new acute respiratory care technologies, announced today that it has received approval - [Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System’s Convertible Dual Lumen Cannula Device and Method of Use](https://inspira-technologies.com/inspira-technologies-granted-patent-by-u-s-patent-office-for-the-inspira-art-systems-convertible-dual-lumen-cannula-device-and-method-of-use/) - All 20 claims were found to be novel, with inventive step and industrial applicability Ra’anana, Israel, January 23, 2023 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that the novel convertible dual lumen cannula device and method of use, being - [Diamond Equity Research Initiates Coverage on Inspira Technologies Ltd. (NASDAQ: IINN)](https://inspira-technologies.com/diamond-equity-research-initiates-coverage-on-inspira-technologies-ltd-nasdaq-iinn/) - NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Inspira Technologies Ltd. (NASDAQ: IINN). The in-depth 22-page initiation report includes detailed information on the Inspira Technologies’ business model, services, industry, valuation, management, and risks. The - [Inspira™ Technologies Signs Strategic Agreement in U.S. to potentially provide $59 million for Inspira for deployment of 3,889 HYLA™ Blood Sensors](https://inspira-technologies.com/inspira-technologies-signs-strategic-agreement-in-u-s-to-potentially-provide-59-million-for-inspira-for-deployment-of-3889-hyla-blood-sensors/) - The agreement signed with Glo-Med Networks for the potential deployment of HYLA™ Blood Sensors over a 3-year period, subject to regulatory approvals July 7, 2022 Ra’anana, Israel, July 7, 2022 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, following yesterday’s announcement - [Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, Ahead of Planned 2023 FDA Submission](https://inspira-technologies.com/inspira-technologies-begins-manufacturing-of-the-alice-cpb-device-ahead-of-planned-2023-fda-submission/) - The ALICE device is an important part of Inspira's market penetration strategy Ra’anana, Israel, December 20, 2022 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that it has begun the manufacturing process for the ALICE CPB (Cardiopulmonary Bypass) device (the - [Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular](https://inspira-technologies.com/inspira-technologies-signs-strategic-oem-agreement-with-terumo-cardiovascular/) - Terumo Cardiovascular is a division of Terumo Corporation, a leading medical device company operating in 160+ countries and regions Ra’anana, Israel, December 27, 2022 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that it has signed an exclusive OEM (Original - [VP clinical affairs video presents the upcoming clinical trial in Sheba hospital](https://inspira-technologies.com/vp-clinical-affairs-video-presents-the-upcoming-clinical-trial-in-sheba-hospital/) - [Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor](https://inspira-technologies.com/inspira-technologies-signs-agreement-to-conduct-clinical-study-of-hyla-blood-sensor/) - The agreement with Sheba Medical Center, 10th ranked hospital in the world*, to be the first site for the HYLA Blood Sensor's Clinical Study December 14, 2022 Ra’anana, Israel- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that it has - [Inspira™ Technologies Reports Third Quarter 2022 Financial Results](https://inspira-technologies.com/inspira-technologies-reports-third-quarter-2022-financial-results/) - As of September 30, 2022, the Company had $16.2 million in cash, cash equivalents, and short-term bank deposits For the full report, please click here - [Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 Million for Deployment of 1,364 HYLA™ Blood Sensors](https://inspira-technologies.com/inspira-technologies-signs-a-strategic-agreement-in-europe-to-potentially-provide-26-1-for-deployment-of-1364-hyla-blood-sensors/) - The agreement signed with Innovimed is over a 5-year period, subject to regulatory approvals Ra’anana, Israel, November 22, 2022 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that it has signed an exclusive distribution agreement for the HYLA Blood Sensor - [Inspira™ Technologies Performed HYLA™ Blood Sensor In-Vivo Study, in Preparation of Planned Human Studies](https://inspira-technologies.com/inspira-technologies-performed-hyla-blood-sensor-in-vivo-study-in-preparation-of-planned-human-studies/) - The study team included leading ICU and respiratory specialists from Company’s Scientific Advisory Board September 7, 2022 Ra’anana, Israel, September 7, 2022 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announces the completion of an animal study that was conducted at - [Inspira™ Technologies to Present at the H.C. Wainwright 24th Annual Global Investor Conference](https://inspira-technologies.com/inspira-technologies-to-present-at-the-h-c-wainwright-24th-annual-global-investor-conference/) - Ra’anana, Israel, September 1, 2022 – Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, today announced that Joe Hayon, President and Co-Founder of Inspira Technologies, will present at the H.C. Wainwright 24th Annual Global Investor Conference on Monday, September 12, 2022. The presentation - [Inspira™ Technologies Reports Second Quarter 2022 Financial Results](https://inspira-technologies.com/inspira-technologies-reports-second-quarter-2022-financial-results/) - As of June 30, 2022, the Company had $19.2 million in cash For the full report, please click here - [Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients - Potentially Targets $2.5 Billion ABG Market](https://inspira-technologies.com/inspira-technologies-develops-a-non-invasive-blood-sensor-designed-to-alert-real-time-change-in-patients-potentially-targets-2-5-billion-abg-market/) - HYLA™ blood sensor intends to reduce the need for actual blood samples to be taken from patients July 06, 2022 Ra’anana, Israel– Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, revealed the development of the HYLA™ blood sensor. Without the need to - [Inspira™ Technologies Announces 2022 first Quarter Financial Results](https://inspira-technologies.com/inspira-technologies-announces-2022-first-quarter-financial-results/) - For the full report, please click here - [Inspira™ Technologies to Participate in Upcoming Events in May](https://inspira-technologies.com/inspira-technologies-to-participate-in-upcoming-events-in-may/) - May 3, 2022 Ra’anana, Israel, Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, today announced that the Company will participate in the following events in May: The Medtech Forum 2022 Format: one-on-one meetings When: May 3-5 Where: Barcelona International Convention Center, Barcelona, - [Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M](https://inspira-technologies.com/inspira-technologies-announces-deployment-agreement-in-the-israeli-market-to-target-15m/) - The Agreement is for a 7-year Period, Subject to Regulatory Approval April 6, 2022 RA'ANANA, Israel, Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (“Inspira” or the “Company”) announced today the execution of a summary distribution agreement with Bepex Ltd. (established in 1969) (“Bepex”) that includes the potential future deployment of Inspira’s ART - [Inspira Technologies Releases Q4 & FY2021 Financial Results](https://inspira-technologies.com/inspira-technologies-releases-q4-fy2021-financial-results-2/) - March 31, 2022 RA'ANANA, Israel, Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW),has released its financial results for 2021 by posting an update on its Investor Relations website. Please click here to view the CEO update. Investor Relations Contact: Miri Segal, MS-IR LLC +917-607-8654 msegal@ms-ir.com, info@inspirao2.com - [Inspira Technologies Releases Q4 & FY2021 Financial Results - CEO Update](https://inspira-technologies.com/inspira-technologies-releases-q4-fy2021-financial-results/) - [Inspira Technologies Is Awarded the 2021 Frost & Sullivan Technology Innovation Leadership Award](https://inspira-technologies.com/inspira-technologies-is-awarded-the-2021-frost-sullivan-technology-innovation-leadership-award/) - Ra’anana, Israel, February 28, 2022 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that it has been awarded the 2021 Europe Technology Innovation Leadership Award in the artificial respiratory market by Frost & Sullivan, a global research consulting firm with extensive - [Inspira Technologies - Awarded with the 2021 Frost & Sullivan Best Practices Technology Innovation Leadership Award](https://inspira-technologies.com/inspira-technologies-awarded-with-the-2021-frost-sullivan-best-practices-technology-innovation-leadership-award/) - Inspira Technologies - Awarded with the 2021 Frost & Sullivan Best Practices Technology Innovation Leadership Award Inspira Technologies has been awarded with the Frost & Sullivan’s 2021 European Technology Innovation Leadership Award in the artificial respiratory market for its minimally invasive and cost-effective technology. The ART system- an early extracorporeal respiratory support system with - [The Respiratory Care Market – Factors Driving the Market and Opportunities for Inspira Technologies' Products](https://inspira-technologies.com/the-respiratory-care-market-factors-driving-the-market-and-opportunities-for-inspira-technologies-products/) - In the last few years, especially during the COVID-19 pandemic, numerous reports and publications have predicted an increase in demand for critical care equipment, such as invasive mechanical ventilation machines and extracorporeal life support systems.[1] The increasing prevalence of chronic disorders and an increasing geriatric population, which is typically at a high risk of - [Inspira Technologies to Present at the Aegis Capital Corp. Virtual Conference](https://inspira-technologies.com/1292-2/) - Inspira Technologies to Present at the Aegis Capital Corp. Virtual Conference Ra’anana, Israel, February 9, 2022 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW), a groundbreaking respiratory support technology company, today announced that Joe Hayon, Inspira’s President & Chief Financial Officer will present at the Aegis Virtual Event on February 23, 2022 at - [Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals](https://inspira-technologies.com/inspira-technologies-signs-a-strategic-agreement-in-the-u-s-to-target-212-million-for-inspira-over-a-7-year-period-subject-to-regulatory-approvals/) - Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals The agreement is with U.S. based Glo-Med Networks for the potential deployment of 2,121 ART Systems in 6 U.S. States Ra’anana, Israel, January 31, 2022 – Inspira Technologies OXY B.H.N. - [Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period](https://inspira-technologies.com/inspira-technologies-signs-a-strategic-agreement-in-the-u-s-to-target-212-million-for-inspira-over-a-7-year-period/) - Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals The agreement is with U.S. based Glo-Med Networks for the potential deployment of 2,121 ART Systems in 6 U.S. States Ra’anana, Israel, January 31, 2022 – Inspira Technologies OXY B.H.N. - [Prof Eddy Fan has joined Inspira's Scientific Advisory Board](https://inspira-technologies.com/prof-eddy-fan-has-joined-inspiras-scientific-advisory-board/) - Inspira Technologies: Professor Eddy Fan, Expert in Critical Care Medicine and Extracorporeal Support, Joins Inspira's Scientific Advisory Board Prof. Fan currently serves as the medical director of the extracorporeal life support program at the Toronto General Hospital Ra’anana, Israel, November 30, 2021 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira - [Inspira Technologies Files a PCT Patent Application for its Flagship ART Device and Proprietary Method of Use](https://inspira-technologies.com/inspira-technologies-files-a-pct-patent-application-for-its-flagship-art-device-and-proprietary-method-of-use/) - Inspira Technologies Files a PCT Patent Application for its Flagship ART Device and Proprietary Method of Use to Minimize the Need for Mechanical Ventilation The ART device is an early-stage extracorporeal respiratory support system designed to treat patients while awake and breathing spontaneously Ra’anana, Israel, December 8, 2021 – Inspira Technologies OXY B.H.N. Ltd. - [Inspira Technologies Signs Strategic Agreement with Innovimed](https://inspira-technologies.com/inspira-technologies-signs-strategic-agreement-with-innovimed-for-the-potential-deployment-of-1522-art-systems-in-poland-czech-republic-slovakia/) - Inspira Technologies Expands in Europe: Signs a Strategic Agreement with Innovimed for the Potential Deployment of 1,522 ART Systems in Poland, Czech Republic & Slovakia The agreement to target $108 million for Inspira Technologies over a 7-year period, subject to regulatory approvals Ra’anana, Israel, December 9, 2021 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: - [Professor Daniel Brodie, Director of Critical Care from New-York Columbia - Presbyterian Hospital, Has Joined Inspira Technologies' Advisory Board](https://inspira-technologies.com/professor-daniel-brodie-director-of-critical-care-from-new-york-columbia-presbyterian-hospital-has-joined-inspira-technologies-advisory-board/) - Professor Daniel Brodie, the President-Elect of the International Extracorporeal Organization (ELSO) and Director of Critical Care from New-York Columbia - Presbyterian Hospital, Has Joined Inspira Technologies' Advisory Board Ra’anana, Israel, January 19, 2022 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced - [Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system](https://inspira-technologies.com/inspira-technologies-has-listed-an-fda-class-i-510k-exempt-component-of-the-art-system/) - Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system Ra’anana, Israel, January 28, 2022 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that has listed a component of its ART and ECLS systems on the - [Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO)](https://inspira-technologies.com/inspira-technologies-appointed-an-expert-in-the-field-of-artificial-lung-as-the-new-chief-technology-officer-cto/) - Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD Ra’anana, Israel, February 3, 2022 – Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that Daniella Yeheskely-Hayon PhD, an - [Inspira Technologies Announces 2021 Third Quarter Financial Results; In October 2021, Company increases cash balance by $9.4 Million due to investors Exercising Warrants](https://inspira-technologies.com/inspira-technologies-announces-2021-third-quarter-financial-results-in-october-2021-company-increases-cash-balance-by-9-4-million-due-to-investors-exercising-warrants/) - PR- 3rd quarter results 2021 - Sullivan - Final 23.11.2021 - [Dr. Stephane Ledot, an Expert in Critical Care and Anesthesia, Has Joined Inspira Technologies' Scientific Advisory Board](https://inspira-technologies.com/dr-stephane-ledot-an-expert-in-critical-care-and-anesthesia-has-joined-inspira-technologies-scientific-advisory-board/) - Inspira - PR Stephane Ledot has joined Inspiras Scientific Advisory Board (November 2021) (4892-4663-5780.1) - [Joe Hayon Presents at the H.C. Wainright 7th Annual Israel Conference](https://inspira-technologies.com/joe-hayon-presents-at-the-h-c-wainright-7th-annual-israel-conference/) - [Inspira to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference](https://inspira-technologies.com/inspira-to-present-at-the-h-c-wainwright-7th-annual-israel-virtual-conference/) - Inspira to Participate at the HCW Virtual Israel Conf Nov 2021 - [Inspira Technologies Files a PCT Patent Application for its Novel Dual Lumen Cannula Used for Blood Oxygenation](https://inspira-technologies.com/inspira-technologies-files-a-pct-patent-application-for-its-novel-dual-lumen-cannula-used-for-blood-oxygenation/) - Dual Lumen Cannula PCT Patent Application - November 2021 - [Inspira Technologies Signs a Strategic Agreement With Waas Group](https://inspira-technologies.com/inspira-technologies-enters-europe-signs-a-strategic-agreement-with-waas-group-for-the-deployment-of-1040-art-systems-in-spain-and-portugal/) - Inspira has signed a distribution agreement with Wass Group 26.10.2021 - [Has COVID changed the game and what are the opportunities for Inspira's ART device? Dr. Kassif, The Chairman of the Israeli ECMO Society](https://inspira-technologies.com/has-covid-changed-the-game-and-what-are-the-opportunities-for-inspira-technologies-art-device-dr-yigal-kassif-the-chairman-of-the-israeli-ecmo-society/) - Has COVID changed the game and what are the opportunities for Inspira Technologies' ART device? Dr. Yigal Kassif, The Chairman of the Israeli ECMO Society Awake ECMO is a specific treatment that the medical community has advanced its understanding and experience in due to the COVID-19 pandemic. The medical community has implemented this treatment in - [Inspira Technologies to Present In-Person at the HLTH Conference in Boston](https://inspira-technologies.com/inspira-technologies-to-present-in-person-at-the-hlth-conference-in-boston/) - Inspira Presents In-Person at HLTH Conference 10.2021 - [Listen To Joe Hayon, Inspira-Technologies’ President, CFO & Co-Founder, Sharing Inspira’s Sharing The Company’s Go-To-Market Strategy](https://inspira-technologies.com/listen-to-joe-hayon-inspira-technologies-president-cfo-co-founder-sharing-inspiras-sharing-the-companys-go-to-market-strategy/) - [Inspira Technologies to Host COVID-19 Virtual Conference on October 6](https://inspira-technologies.com/inspira-technologies-to-host-covid-19-virtual-conference-on-october-6/) - [Inspira Technologies Announces First Half 2021 Financial Results and Provides Business Update](https://inspira-technologies.com/inspira-technologies-announces-first-half-2021-financial-results-and-provides-business-update/) - [Inspira Technologies Files a Patent Application for a Supportive Device to be Utilized with the ART Device](https://inspira-technologies.com/inspira-technologies-files-a-patent-application-for-a-supportive-device-to-be-utilized-with-the-art-device/) - [Inspira Technologies Expands Board of Directors to Accelerate Company’s Go-to-Market Efforts](https://inspira-technologies.com/inspira-technologies-expands-board-of-directors-to-accelerate-companys-go-to-market-efforts/) - [Inspira Technologies to Participate in Upcoming Conferences in September](https://inspira-technologies.com/inspira-technologies-to-participate-in-upcoming-conferences-in-september/) - [Inspira Technologies Reveals the AXT - An Intelligent System that Directly Oxygenates Blood for Respiratory Care](https://inspira-technologies.com/inspira-technologies-reveals-the-axt-an-intelligent-system-that-directly-oxygenates-blood-for-respiratory-care/) - [Inspira Technologies Files U.S. Patent Application for its Innovative Respiratory Support Technology; Engages Leading U.S. Investment Bank for NASDAQ Listing](https://inspira-technologies.com/inspira-technologies-files-u-s-patent-application-for-its-innovative-respiratory-support-technology-engages-leading-u-s-investment-bank-for-nasdaq-listing/) - [Inspira Technologies and Sheba Medical Center Collaborate on Breakthrough Respiration Treatment](https://inspira-technologies.com/inspira-technologies-and-sheba-medical-center-collaborate-on-breakthrough-respiration-treatment/) - [Inspira Technologies OXY B.H.N. Ltd Announces Pricing of Initial Public Offering](https://inspira-technologies.com/inspira-technologies-oxy-b-h-n-ltd-announces-pricing-of-initial-public-offering/) - [Inspira Technologies Reached Important Milestone as It Completed a Pump Bench Study](https://inspira-technologies.com/inspira-technologies-reached-important-milestone-as-it-completed-a-pump-bench-study/) - [Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering](https://inspira-technologies.com/inspira-technologies-oxy-b-h-n-ltd-announces-closing-of-initial-public-offering/) - [Inspira Technologies' "Artificial Lung" to Acquire a Digital Edge: The Company Contracted GlobalLogic, a Hitachi Group Company, for Advanced Digital Product Engineering Services](https://inspira-technologies.com/inspira-technologies-artificial-lung-to-acquire-a-digital-edge-the-company-contracted-globallogic-a-hitachi-group-company-for-advanced-digital-product-engineering-services/) - [Inspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent Blood Clotting in Inspira's ART System](https://inspira-technologies.com/inspira-technologies-and-ben-gurion-university-have-developed-a-platform-designed-to-prevent-blood-clotting-in-inspiras-art-system/) - [Inspira Expands Medical Advisory Board as Part of Future Expansion into North American Market](https://inspira-technologies.com/inspira-expands-medical-advisory-board-as-part-of-future-expansion-into-north-american-market/) - [INSPIRA-Technologies Announces New Medical Advisory Board Member – Dr. Avraham Abutbul – Specialist in Internal Medicine, General Intensive Care Medicine and Pulmonary Medicine](https://inspira-technologies.com/inspira-technologies-announces-new-medical-advisory-board-member-dr-avraham-abutbul-specialist-in-internal-medicine-general-intensive-care-medicine-and-pulmonary-medicine/) - [Inspira Technologies Appoints Benad Goldwasser As Chairman Of The Board](https://inspira-technologies.com/inspira-technologies-appoints-benad-goldwasser-as-chairman-of-the-board/) - [Inspira Technologies](https://inspira-technologies.com/inspira-technologies/) - [Breakthrough Oxygenation | Professor Benad Goldwasser](https://inspira-technologies.com/breakthrough-oxygenation-professor-benad-goldwasser/) - [This IPO Stock Resembles Nanox, Is Inspira IINN Stock A Buy](https://inspira-technologies.com/this-ipo-stock-resembles-nanox-is-inspira-iinn-stock-a-buy/) - [Inspira’s Proprietary Augmented Respiration Technology (ART)](https://inspira-technologies.com/inspiras-proprietary-augmented-respiration-technology-art/) ## Pages - [Home](https://inspira-technologies.com/) - Inspira Technologies pioneers respiratory care with INSPIRA™ ART, an innovative alternative to invasive mechanical ventilation. Explore our solutions >> - [INSPIRA™ ART500](https://inspira-technologies.com/art/) - Discover INSPIRA™ ART, a breakthrough in respiratory care designed to oxygenate blood directly while patients remain awake, avoiding invasive mechanical ventilation. - [INSPIRA™ ART100](https://inspira-technologies.com/inspira-art100/) - Revolutionize CPB procedures with INSPIRA™ ART100, a reliable, FDA-cleared system for blood oxygenation during cardiac surgery. Discover clinical results >> - [News & Events](https://inspira-technologies.com/news/) - Stay updated with Inspira Technologies (NASDAQ: IINN) news. Explore press releases on INSPIRA™ ART, HYLA™ sensor, and strategic MedTech breakthroughs >> - [About](https://inspira-technologies.com/about/) - Inspira Technologies is a NASDAQ-listed innovator (IINN) redefining the respiratory care market. Meet the team and explore our vision for the future of MedTech - [HYLA™ Blood Monitoring System](https://inspira-technologies.com/hyla/) - HYLA™ is a non-invasive blood sensor for real-time monitoring. Discover how Inspira is revolutionizing blood gas analysis for respiratory care>> - [Investor Relations](https://inspira-technologies.com/investor-relations/) - [Knowledge Center](https://inspira-technologies.com/knowledge-center/) - [Quality Management Systems](https://inspira-technologies.com/qms/) - [Raffle Winner 2024](https://inspira-technologies.com/raffle-winner-2024/) - [INSPIRA™ ART100](https://inspira-technologies.com/inspira-art100-old/) - [Inspira Raffle 2024](https://inspira-technologies.com/inspira-raffle-2024/) - [Inspira Raffle](https://inspira-technologies.com/raffle/) - [Unsubscribe from PR emails](https://inspira-technologies.com/unsubscribe-pr/) - [Raffle Winner](https://inspira-technologies.com/raffle-winner/) - [Terms & conditions](https://inspira-technologies.com/terms/) - INSPIRA TECHNOLOGIES OFFICIAL SWEEPSTAKES RULES How to Enter. At the 34th Annual ELSO Conference, at Hyatt Regency Seattle, WA (the “Conference”) on September 29, 2023 and September 30, 2023, visit the Inspira Technologies (“Inspira”) booth to scan the QR code provided and follow the on-screen entry instructions. Fill in your first name, last name, phone - [Careers](https://inspira-technologies.com/careers/) - [Privacy Notice for Candidates](https://inspira-technologies.com/privacy-notice-for-candidates/) - Privacy Notice for Candidates This privacy notice (the “Notice”) describes the ways that the company recruiting you as a candidate (“Company”, “we”, “us”, “our”), collects and uses your personal data as a candidate (“you” or “candidate”). We work with data processors to whom we have instructed to collect, store and process personal information on our - [Afternoon Cocktails](https://inspira-technologies.com/afternoon-cocktails/) - [Thank you!](https://inspira-technologies.com/thank-you/) - Your message has been sent successfully. - [Privacy Policy](https://inspira-technologies.com/privacy-policy/) - Who we are Suggested text: Our website address is: https://inspira-technologies.com. Comments Suggested text: When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. An anonymized string created from your email address (also called a ## Jobs - [Manufacturing NPI & Configuration Leader](https://inspira-technologies.com/job/manufacturing-npi-configuration-leader/) - We are looking for a Manufacturing NPI & Configuration Leader to be a Member of the Operations department. - [Mechanical Engineer - Medical Device](https://inspira-technologies.com/job/mechanical-engineer-medical-device/) - We are now looking for a Mechanical Engineer to join us and be part of our inspiration. - [Medical Device System V&V](https://inspira-technologies.com/job/medical-device-system-vv/) - We are now looking for a Medical Device V&V lead. How has experience in managing, planning, and executing the product V&V process, and want to join our inspiration! - [R&D Researcher](https://inspira-technologies.com/job/rd-researcher/) - We are looking for Researcher to be part of our R&D department. This is your Opportunity to join a fast-growing company, with the potential to disrupt a billion dollar industry and touch millions of lives by developing a unique medical device solution. ## Articles - [INSPIRA™ ART100 - Instructions for Use](https://inspira-technologies.com/article/inspira-art100-instructions-for-use/) - [INSPIRA™ CART - Instructions for Use](https://inspira-technologies.com/article/inspira-cart-instructions-for-use/) - [INSPIRA™ ART100 - Quick Reference Guide](https://inspira-technologies.com/article/inspira-art100-quick-reference-guide/) - [Opportunities for the ART500 system following the COVID-19 pandemic- Dr. Dekel Stavi](https://inspira-technologies.com/article/opportunities-for-the-art-system-following-the-covid-19-pandemic-dr-dekel-stavi/) - [Who benefits from INSPIRA ART500 system?](https://inspira-technologies.com/article/who-benefits-from-art-system/) - [The difference between INSPIRA ART500 and ECMO](https://inspira-technologies.com/article/the-difference-between-art-and-ecmo/) - [INSPIRA ART500s proprietary components](https://inspira-technologies.com/article/arts-proprietary-components/) - [About INSPIRA ART500 System](https://inspira-technologies.com/article/about-art-system/) - [Blood Monitoring Pattern Utilization During CPB Procedures](https://inspira-technologies.com/article/blood-monitoring-pattern-utilization-during-cpb-procedures/) - Online survey results, January 2023 - [Oxygenator Design - Present & Future Challenges](https://inspira-technologies.com/article/oxygenator-design-present-future-challenges/) - Written by Daniella Yeheskely – Hayon, PhD, MBA Chief Technology Officer - [Low Flow Extracorporeal Oxygenation Approach is the Future of Acute Respiratory Care](https://inspira-technologies.com/article/low-flow-extracorporeal-oxygenation-approach-is-the-future-of-acute-respiratory-care/) - [Inspira's pre clinical studies presentation](https://inspira-technologies.com/article/inspiras-pre-clinical-studies-presentation/) - Inspira pre-clinical studies - October 2022 - [Dr. Yigal Kassif - Has Covid changed the game?](https://inspira-technologies.com/article/dr-yigal-kassif-has-covid-changed-the-game/) - [Inspira's pre-clinical studies video](https://inspira-technologies.com/article/inspiras-pre-clinical-studies-video/) ## Categories - [Uncategorized](https://inspira-technologies.com/category/uncategorized/)